BioNTech is developing novel Antibody-Drug Conjugates (ADCs), protein degraders and other targeted therapeutics for the targeted treatment of cancer with the goal of maximizing efficacy and minimizing toxic effects to patients. To achieve this goal ADCs and/or degraders will be prepared, evaluated in a battery of in vitro and in vivo assays, then based on results, improved therapeutics will be developed. Are you ready to make a significant impact in the oncology field? We are seeking a highly motivated and independent Scientist to join our ADC Innovation Unit in Cambridge, MA. Become a part of a multidisciplinary team of Global ADC Innovation Unit, supporting antibody-drug conjugate (ADC) research programs
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees